FT Pharma 2013: Bayer chairman Marijn Dekkers says 'patients don't appreciate us'

3 December 2013

Most patients don’t appreciate the pharma companies that save their lives, Bayer chairman and chief executive Marijn Dekkers told the Financial Times Global Pharmaceutical & Biotechnology Conference in London today.

Dr Dekkers gave a keynote address before joining in a panel discussion of the reputation of the pharma industry. He said: “Most patients don’t really appreciate the pharma company that might cure them or extend their life. Everybody knows the brand of their mobile phone or their car, but they don’t know who made the drug that saved their life.”

This lack of interest has wider implications, he added, and influences key decision makers.  “If the voters don’t really value the pharma industry, then the politicians won’t either,” he said.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More on this story...



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical